Albemarle is a chemicals - specialty company in the basic materials sector trading on NYSE, led by CEO Jerry Kent Jr., with a market cap of $21.2B.
Upcoming earnings announcement for Albemarle
Past 12 earnings reports for Albemarle
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Q4 2025 | -$0.53Est: -$0.49 | -8.2% | $1.4BEst: $1.3B | +5.8% | |
| Nov 5, 2025 | Q3 2025 | -$0.19Est: -$0.89 | +78.7% | $1.3BEst: $1.3B | +1.8% | |
| Jul 30, 2025 | Q2 2025 | $0.11Est: -$0.81 | +113.6% | $1.3BEst: $1.2B | +7.8% | |
| Apr 30, 2025 | Q1 2025 | -$0.18Est: -$0.66 | +72.7% | $1.1BEst: $1.2B | -7.2% | — |
| Feb 12, 2025 | Q4 2024 | -$1.09Est: -$0.67 | -62.7% | $1.2BEst: $1.3B | -8.1% | |
| Nov 6, 2024 | Q3 2024 | -$1.55Est: -$0.44 | -252.3% | $1.4BEst: $1.4B | -1.1% | |
| Jul 31, 2024 | Q2 2024 | $0.04Est: $0.41 | -90.2% | $1.4BEst: $1.4B | +5.9% | |
| May 1, 2024 | Q1 2024 | $0.26Est: $0.27 | -3.7% | $1.4BEst: $1.3B | +3.9% | |
| Feb 14, 2024 | Q4 2023 | $1.85Est: $1.01 | +83.2% | $2.4BEst: $2.2B | +8.1% | |
| Nov 1, 2023 | Q3 2023 | $2.74Est: $4.05 | -32.3% | $2.3BEst: $2.6B | -9.4% | — |
| Aug 2, 2023 | Q2 2023 | $7.33Est: $4.44 | +65.1% | $2.4BEst: $2.4B | -2.5% | — |
| May 3, 2023 | Q1 2023 | $10.32Est: $7.03 | +46.8% | $2.6BEst: $2.7B | -5.5% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.